{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:22Z","timestamp":1761511642029},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7754,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1023\/a:1008497322508","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:30:06Z","timestamp":1040549406000},"page":"1127-1130","source":"Crossref","is-referenced-by-count":39,"title":["Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study"],"prefix":"10.1016","volume":"9","author":[{"given":"N.","family":"Androulakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kouroussis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kakolyris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tzannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Geroyianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Georgopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Souglakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kotsakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vardakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hatzidaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008497322508_bb0010","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (Taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008497322508_bb0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/85.5.388","article-title":"Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Easten Cooperative Group results. J NatI","volume":"85","author":"Chang","year":"1993","journal-title":"Cancer Inst"},{"key":"10.1023\/A:1008497322508_bb0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnci\/85.5.384","article-title":"Phase II study of Taxol in patients with untreated advanced non-small-cell lung cancer","volume":"85","author":"Murphy","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008497322508_bb0025","first-page":"366","article-title":"Taxol is active as a three-hour or 24-hour infusion in non-small-cell lung cancer","volume":"14","author":"Tan","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008497322508_bb0030","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1200\/JCO.1995.13.7.1609","article-title":"Paclitaxel by one-hour infusion: An active drug in metastatic non-small-cell lung cancer","volume":"13","author":"Hainsworth","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008497322508_bb0035","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1200\/JCO.1994.12.8.1535","article-title":"Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study","volume":"12","author":"Abratt","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008497322508_bb0040","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1200\/JCO.1994.12.9.1821","article-title":"Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: A phase II study","volume":"12","author":"Anderson","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008497322508_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0959-8049(95)00444-0","article-title":"Activity of gemcitabine in patients with non-smal-cell lung cancer: A multicentre, extended phase II study","volume":"34A","author":"Gatzemeir","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008497322508_bb0050","first-page":"1603","article-title":"Salvage therapy with gemcitabine in pretreated, advanced non-small-cell lung cancer","volume":"16","author":"Crino","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl 10","key":"10.1023\/A:1008497322508_bb0055","first-page":"3","article-title":"Gemcitabine: Preclinical pharmacology and mechanisms of action","volume":"23","author":"Plunkett","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008497322508_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer research","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"Suppl 8","key":"10.1023\/A:1008497322508_bb0065","first-page":"543","article-title":"A phase I study to investigate alternate sequencing of the combination of gemcitabine and paclitaxel in ovarian carcinoma","volume":"33","author":"Poole","year":"1997","journal-title":"Eur J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419482148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419482148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/10\/1127\/19481405\/9-10-1127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T12:04:10Z","timestamp":1582200250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419482148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["S0923753419482148"],"URL":"https:\/\/doi.org\/10.1023\/a:1008497322508","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}